Your browser doesn't support javascript.
loading
A clash on the Toll pathway: competitive action between pesticides and zymosan A on components of innate immunity in Apis mellifera.
Sukkar, Dani; Kanso, Ali; Laval-Gilly, Philippe; Falla-Angel, Jairo.
Affiliation
  • Sukkar D; Laboratoire Sols et Environnement, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Université de Lorraine, Nancy, France.
  • Kanso A; Biology Department, Faculty of Sciences I, Lebanese University, Hadath, Lebanon.
  • Laval-Gilly P; Biology Department, Faculty of Sciences I, Lebanese University, Hadath, Lebanon.
  • Falla-Angel J; Laboratoire Sols et Environnement, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Université de Lorraine, Nancy, France.
Front Immunol ; 14: 1247582, 2023.
Article de En | MEDLINE | ID: mdl-37753094
ABSTRACT

Background:

The immune system of honeybees includes multiple pathways that may be affected by pesticide exposure decreasing the immune competencies of bees and increasing their susceptibility to diseases like the fungal Nosema spp. infection, which is detected in collapsed colonies.

Methods:

To better understand the effect of the co-presence of multiple pesticides that interact with bees like imidacloprid and amitraz, we evaluated the expression of immune-related genes in honeybee hemocytes.

Results:

Imidacloprid, amitraz, and the immune activator, zymosan A, mainly affect the gene expression in the Toll pathway.

Discussion:

Imidacloprid, amitraz, and zymosan A have a synergistic or an antagonistic relationship on gene expression depending on the level of immune signaling. The presence of multiple risk factors like pesticides and pathogens requires the assessment of their complex interaction, which has differential effects on the innate immunity of honeybees as seen in this study.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: Front Immunol Année: 2023 Type de document: Article Pays d'affiliation: France

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: Front Immunol Année: 2023 Type de document: Article Pays d'affiliation: France